Based on the sequencing data from the TCGA database in cBioPortal, researchers have found TKS5 mutations or alterations in around 4% of the samples from urinary tract cancer, and in more than 13% of the samples from uterine carcinosarcoma [41,42]. This evidence concerns the gene SH3PXD2A and uterine carcinosarcoma.